PodParley PodParley
PodParley
Efficacy and Safety of Trastuzumab Deruxtecan vs Physician’s Choice of Chemotherapy by Pace of Disease Progression on Prior Endocrine-based Therapy - report from SABCS2024 episode artwork

EPISODE · Dec 20, 2024 · 2 MIN

Efficacy and Safety of Trastuzumab Deruxtecan vs Physician’s Choice of Chemotherapy by Pace of Disease Progression on Prior Endocrine-based Therapy - report from SABCS2024

from Medical Digest & Congress Report · host Medical Congress News

Prof. Giuseppe Curigliano presents the data of the DESTINY-Breast06 at San Antonio Breast Cancer Symposium 2024. Video: https://medicaldigest.org/scientific-contents/interview:efficacy-and-safety-trastuzumab-deruxtecan-vs-physicians-choice-chemotherapy-pace-disease-progression-prior-endocrine-based-therapy

Episode metadata supplied by the publisher feed · Published Dec 20, 2024

Embed this episode

Ready to play

Efficacy and Safety of Trastuzumab Deruxtecan vs Physician’s Choice of Chemotherapy by Pace of Disease Progression on Prior Endocrine-based Therapy - report from SABCS2024

0:00 2:13

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 2 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on December 20, 2024.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!